Global Sepsis Diagnostics Market: Size, Trend, Share, Opportunity Analysis & Forecast, 2014–2025

February 2017 | | ID: G44FA687D9AEN
Progressive Markets (owned by Antviews Global)

Abstracts

Sepsis is a bloodstream infection in which there is a massive immune response and may lead to organ failure. The bloodstream infection arises from other organ infections such as skin, abdomen, lungs, and urinary tract. Patients with sepsis are treated in the intensive care unit and early treatment increases the chances of survival. According to the center for disease control, in 2008, $14.6 billion was spent on hospitalization of sepsis patients. In most cases, sepsis is fatal and those who survive from sepsis may have permanent organ failure, physical disability, and cognitive impairment. Diagnosis of sepsis is difficult as its signs and symptoms are like other infections. There are different tests for the confirmation of sepsis such as blood tests, urine test, wound secretion test, respiratory secretions, and imaging scans such as X-ray, CT scan, ultrasound, and magnetic resonance. The global sepsis diagnostics market is expected to grow at a CAGR of 9.2% from 2017 to 2025.

Based on product type, the market is divided into blood culture media, instruments, assays & reagents, and software. According to technology, the market is divided into immunoassays, flow cytometry, microbiology, and molecular diagnostics. Based on method, the market is bifurcated into conventional diagnostics and automated diagnostics. According to usability, the market is segmented as laboratory testing and point-of-care testing. Pathogen is segmented as fungal sepsis, bacterial sepsis, gram-positive bacterial sepsis, gram-negative bacterial sepsis, and others. Geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.

MARKET DYNAMICS:

Drivers:

• Increase in geriatric population.
• Rising number of hospital based infections.
• Increase in healthcare expenditure.
• Technological advancements.

Restraints:

• Shortage of skilled professionals.
• Lack of standard protocols for the diagnosis of sepsis.

MARKET PLAYERS:

The top players in the global sepsis diagnostics market include T2 Biosystems, Inc., bioMérieux SA, Thermo Fisher Scientific Inc., Cepheid, Nanosphere, Inc., Abbott Laboratories, Becton, Dickinson and Company, Roche Diagnostics Limited, Bruker Corporation, and Beckman Coulter, Inc.

KEY TAKEAWAYS

MARKET LANDSCAPE

• By Product
• Blood Culture Media
• Instruments
• Assays & Reagents
• Software
• By Technology
• Immunoassays
• Flow Cytometry
• Microbiology
• Molecular Diagnostics
• By Method
• Conventional Diagnostics
• Automated Diagnostics
• By Usability
• Laboratory Testing
• Point-of-care Testing
• By Pathogen
• Fungal Sepsis
• Bacterial Sepsis
• Gram-positive Bacterial Sepsis
• Gram-negative Bacterial Sepsis
• Others
• By Geography
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

Contents

1. EXECUTIVE SUMMARY

1.1. Key findings
1.2. Market attractiveness and trend analysis
1.3. Competitive landscape and recent industry development analysis

2. INTRODUCTION

2.1. Report description
2.2. Scope and definitions
2.3. Research methodology

3. MARKET LANDSCAPE

3.1. Growth drivers
  3.1.1. Impact analysis
3.2. Restrains and challenges
  3.2.1. Impact analysis
3.3. Porter’s analysis
  3.3.1. Bargaining power of buyers
  3.3.2. Bargaining power of suppliers
  3.3.3. Threat of substitutes
  3.3.4. Industry rivalry
  3.3.5. Threat of new entrants
3.4. Global sepsis diagnostics market shares analysis, 2014-2025
  3.4.1. Global sepsis diagnostics market share by product, 2014-2025
  3.4.2. Global sepsis diagnostics market share by technology, 2014-2025
  3.4.3. Global sepsis diagnostics market share by method, 2014-2025
  3.4.4. Global sepsis diagnostics market share by usability, 2014-2025
  3.4.5. Global sepsis diagnostics market share by pathogen, 2014-2025
  3.4.6. Global sepsis diagnostics market share by geography, 2014-2025

4. SEPSIS DIAGNOSTICS MARKET BY PRODUCT

4.1. Blood culture media
  4.1.1. Historical market size by region, 2014-2016
  4.1.2. Market forecast by region, 2017-2025
4.2. Instruments
  4.2.1. Historical market size by region, 2014-2016
  4.2.2. Market forecast by region, 2017-2025
4.3. Assays & reagents
  4.3.1. Historical market size by region, 2014-2016
  4.3.2. Market forecast by region, 2017-2025
4.4. Software
  4.4.1. Historical market size by region, 2014-2016
  4.4.2. Market forecast by region, 2017-2025

5. SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY

5.1. Immunoassays
  5.1.1. Historical market size by region, 2014-2016
  5.1.2. Market forecast by region, 2017-2025
5.2. Flow cytometry
  5.2.1. Historical market size by region, 2014-2016
  5.2.2. Market forecast by region, 2017-2025
5.3. Microbiology
  5.3.1. Historical market size by region, 2014-2016
  5.3.2. Market forecast by region, 2017-2025
5.4. Molecular diagnostics
  5.4.1. Historical market size by region, 2014-2016
  5.4.2. Market forecast by region, 2017-2025

6. SEPSIS DIAGNOSTICS MARKET BY METHOD

6.1. Conventional diagnostics
  6.1.1. Historical market size by region, 2014-2016
  6.1.2. Market forecast by region, 2017-2025
6.2. Automated diagnostics
  6.2.1. Historical market size by region, 2014-2016
  6.2.2. Market forecast by region, 2017-2025

7. SEPSIS DIAGNOSTICS MARKET BY USABILITY

7.1. Laboratory testing
  7.1.1. Historical market size by region, 2014-2016
  7.1.2. Market forecast by region, 2017-2025
7.2. Point-of-care testing
  7.2.1. Historical market size by region, 2014-2016
  7.2.2. Market forecast by region, 2017-2025

8. SEPSIS DIAGNOSTICS MARKET BY PATHOGEN

8.1. Fungal sepsis
  8.1.1. Historical market size by region, 2014-2016
  8.1.2. Market forecast by region, 2017-2025
8.2. Bacterial sepsis
  8.2.1. Historical market size by region, 2014-2016
  8.2.2. Market forecast by region, 2017-2025
8.3. Gram-positive bacterial sepsis
  8.3.1. Historical market size by region, 2014-2016
  8.3.2. Market forecast by region, 2017-2025
8.4. Gram-negative bacterial sepsis
  8.4.1. Historical market size by region, 2014-2016
  8.4.2. Market forecast by region, 2017-2025
8.5. Others
  8.5.1. Historical market size by region, 2014-2016
  8.5.2. Market forecast by region, 2017-2025

9. SEPSIS DIAGNOSTICS MARKET BY GEOGRAPHY

9.1. North America
  9.1.1. U.S.
    9.1.1.1. Historical market size, 2014-2016
    9.1.1.2. Market forecast, 2017-2025
  9.1.2. Canada
    9.1.2.1. Historical market size, 2014-2016
    9.1.2.2. Market forecast, 2017-2025
  9.1.3. Mexico
    9.1.3.1. Historical market size, 2014-2016
    9.1.3.2. Market forecast, 2017-2025
9.2. Europe
  9.2.1. UK
    9.2.1.1. Historical market size, 2014-2016
    9.2.1.2. Market forecast, 2017-2025
  9.2.2. Germany
    9.2.2.1. Historical market size, 2014-2016
    9.2.2.2. Market forecast, 2017-2025
  9.2.3. France
    9.2.3.1. Historical market size, 2014-2016
    9.2.3.2. Market forecast, 2017-2025
  9.2.4. Spain
    9.2.4.1. Historical market size, 2014-2016
    9.2.4.2. Market forecast, 2017-2025
  9.2.5. Italy
    9.2.5.1. Historical market size, 2014-2016
    9.2.5.2. Market forecast, 2017-2025
  9.2.6. Rest of Europe
    9.2.6.1. Historical market size, 2014-2016
    9.2.6.2. Market forecast, 2017-2025
9.3. Asia-Pacific
  9.3.1. China
    9.3.1.1. Historical market size, 2014-2016
    9.3.1.2. Market forecast, 2017-2025
  9.3.2. Japan
    9.3.2.1. Historical market size, 2014-2016
    9.3.2.2. Market forecast, 2017-2025
  9.3.3. India
    9.3.3.1. Historical market size, 2014-2016
    9.3.3.2. Market forecast, 2017-2025
  9.3.4. Australia
    9.3.4.1. Historical market size, 2014-2016
    9.3.4.2. Market forecast, 2017-2025
  9.3.5. South Korea
    9.3.5.1. Historical market size, 2014-2016
    9.3.5.2. Market forecast, 2017-2025
  9.3.6. Rest of Asia-Pacific
    9.3.6.1. Historical market size, 2014-2016
    9.3.6.2. Market forecast, 2017-2025
9.4. LAMEA
  9.4.1. Brazil
    9.4.1.1. Historical market size, 2014-2016
    9.4.1.2. Market forecast, 2017-2025
  9.4.2. Saudi Arabia
    9.4.2.1. Historical market size, 2014-2016
    9.4.2.2. Market forecast, 2017-2025
  9.4.3. South Africa
    9.4.3.1. Historical market size, 2014-2016
    9.4.3.2. Market forecast, 2017-2025
  9.4.4. Rest of LAMEA
    9.4.4.1. Historical market size, 2014-2016
    9.4.4.2. Market forecast, 2017-2025

10. COMPANY PROFILES

10.1. T2 biosystems, inc.
  10.1.1. Overview
  10.1.2. Financials and business segments
  10.1.3. Recent developments
10.2. Biomérieux sa
  10.2.1. overview
  10.2.2. Financials and business segments
  10.2.3. Recent developments
10.3. Thermo fisher scientific inc.
  10.3.1. Overview
  10.3.2. Financials and business segments
  10.3.3. Recent developments
10.4. Cepheid
  10.4.1. overview
  10.4.2. Financials and business segments
  10.4.3. Recent developments
10.5. Nanosphere, inc.
  10.5.1. Overview
  10.5.2. Financials and business segments
  10.5.3. Recent developments
10.6. Abbott laboratories
  10.6.1. Overview
  10.6.2. Financials and business segments
  10.6.3. Recent developments
10.7. Becton, dickinson and company
  10.7.1. Overview
  10.7.2. Financials and business segments
  10.7.3. Recent developments
10.8. Roche diagnostics limited
  10.8.1. Overview
  10.8.2. Financials and business segments
  10.8.3. Recent developments
10.9. Bruker corporation
  10.9.1. Overview
  10.9.2. Financials and business segments
  10.9.3. Recent developments
10.10. Beckman coulter, inc.
  10.10.1. Overview
  10.10.2. Financials and business segments
  10.10.3. Recent developments

List Of Tables

LIST OF TABLES

Table 1. Sepsis Diagnostics Market Share, by Product, 2014-2025
Table 2. Sepsis Diagnostics Market Share, by Technology, 2014-2025
Table 3. Sepsis Diagnostics Market Share, by Method, 2014-2025
Table 4. Sepsis Diagnostics Market Share, by Usability, 2014-2025
Table 5. Sepsis Diagnostics Market Share, by Pathogen, 2014-2025
Table 6. Sepsis Diagnostics Market Share, by Region, 2014-2025
Table 7. Sepsis Diagnostics Market Value for Blood Culture Media, by Region, 2017-2025, $million
Table 8. Sepsis Diagnostics Market Value for Instruments, by Region, 2017-2025, $million
Table 9. Sepsis Diagnostics Market Value for Assays & Reagents, by Region, 2017-2025, $million
Table 10. Sepsis Diagnostics Market Value for Software, by Region, 2017-2025, $million
Table 11. Sepsis Diagnostics Market Value for Immunoassays, by Region, 2017-2025, $million
Table 12. Sepsis Diagnostics Market Value for Flow Cytometry, by Region, 2017-2025, $million
Table 13. Sepsis Diagnostics Market Value for Microbiology, by Region, 2017-2025, $million
Table 14. Sepsis Diagnostics Market Value for Molecular Diagnostics, by Region, 2017-2025, $million
Table 15. Sepsis Diagnostics Market Value for Conventional Diagnostics, by Region, 2017-2025, $million
Table 16. Sepsis Diagnostics Market Value for Automated Diagnostics, by Region, 2017-2025, $million
Table 17. Sepsis Diagnostics Market Value for Laboratory Testing, by Region, 2017-2025, $million
Table 18. Sepsis Diagnostics Market Value for Point-of-care Testing, by Region, 2017-2025, $million
Table 19. Sepsis Diagnostics Market Value for Fungal Sepsis, by Region, 2017-2025, $million
Table 20. Sepsis Diagnostics Market Value for Bacterial Sepsis, by Region, 2017-2025, $million
Table 21. Sepsis Diagnostics Market Value for Gram-positive Bacterial Sepsis, by Region, 2017-2025, $million
Table 22. Sepsis Diagnostics Market Value for Gram-negative Bacterial Sepsis, by Region, 2017-2025, $million
Table 23. Sepsis Diagnostics Market Value for Other Pathogen, by Region, 2017-2025, $million
Table 24. Sepsis Diagnostics Market Value for North America, by Country, 2014-2025, $million
Table 25. Sepsis Diagnostics Market Value for North America, by Product, 2014-2025, $million
Table 26. Sepsis Diagnostics Market Value for North America, by Technology, 2014-2025, $million
Table 27. Sepsis Diagnostics Market Value for North America, by Method, 2014-2025, $million
Table 28. Sepsis Diagnostics Market Value for North America, by Usability, 2014-2025, $million
Table 29. Sepsis Diagnostics Market Value for North America, by Pathogen, 2014-2025, $million
Table 30. Sepsis Diagnostics Market Value for Europe, by Country, 2014-2025, $million
Table 31. Sepsis Diagnostics Market Value for Europe, by Product, 2014-2025, $million
Table 32. Sepsis Diagnostics Market Value for Europe, by Technology, 2014-2025, $million
Table 33. Sepsis Diagnostics Market Value for Europe, by Method, 2014-2025, $million
Table 34. Sepsis Diagnostics Market Value for Europe, by Usability, 2014-2025, $million
Table 35. Sepsis Diagnostics Market Value for Europe, by Pathogen, 2014-2025, $million
Table 36. Sepsis Diagnostics Market Value for Asia-Pacific, by Country, 2014-2025, $million
Table 37. Sepsis Diagnostics Market Value for Asia-Pacific, by Product, 2014-2025, $million
Table 38. Sepsis Diagnostics Market Value for Asia-Pacific, by Technology, 2014-2025, $million
Table 39. Sepsis Diagnostics Market Value for Asia-Pacific, by Method, 2014-2025, $million
Table 40. Sepsis Diagnostics Market Value for Asia-Pacific, by Usability, 2014-2025, $million
Table 41. Sepsis Diagnostics Market Value for Asia-Pacific, by Pathogen, 2014-2025, $million
Table 42. Sepsis Diagnostics Market Value for LAMEA, by Country, 2014-2025, $million
Table 43. Sepsis Diagnostics Market Value for LAMEA, by Product, 2014-2025, $million
Table 44. Sepsis Diagnostics Market Value for LAMEA, by Technology, 2014-2025, $million
Table 45. Sepsis Diagnostics Market Value for LAMEA, by Method, 2014-2025, $million
Table 46. Sepsis Diagnostics Market Value for LAMEA, by Usability, 2014-2025, $million
Table 47. Sepsis Diagnostics Market Value for LAMEA, by Pathogen, 2014-2025, $million
Table 48. T2 Biosystems, Inc. - Company Snapshot
Table 49. bioMérieux SA - Company Snapshot
Table 50. Thermo Fisher Scientific Inc. - Company Snapshot
Table 51. Cepheid - Company Snapshot
Table 52. Nanosphere, Inc. - Company Snapshot
Table 53. Abbott Laboratories - Company Snapshot
Table 54. Becton, Dickinson and Company - Company Snapshot
Table 55. Roche Diagnostics Limited - Company Snapshot
Table 56. Bruker Corporation - Company Snapshot
Table 57. Beckman Coulter, Inc. - Company Snapshot

List Of Figures

LIST OF FIGURES

Figure 1. Sepsis Diagnostics: Blood Culture Media Market Value, 2014-2016, $million
Figure 2. Sepsis Diagnostics: Instruments Market Value, 2014-2016, $million
Figure 3. Sepsis Diagnostics: Assays & Reagents Market Value, 2014-2016, $million
Figure 4. Sepsis Diagnostics: Software Market Value, 2014-2016, $million
Figure 5. Sepsis Diagnostics: Immunoassays Market Value, 2014-2016, $million
Figure 6. Sepsis Diagnostics: Flow Cytometry Market Value, 2014-2016, $million
Figure 7. Sepsis Diagnostics: Microbiology Market Value, 2014-2016, $million
Figure 8. Sepsis Diagnostics: Molecular Diagnostics Market Value, 2014-2016, $million
Figure 9. Sepsis Diagnostics: Conventional Diagnostics Market Value, 2014-2016, $million
Figure 10. Sepsis Diagnostics: Automated Diagnostics Market Value, 2014-2016, $million
Figure 11. Sepsis Diagnostics: Laboratory Testing Market Value, 2014-2016, $million
Figure 12. Sepsis Diagnostics: Point-of-care Testing Market Value, 2014-2016, $million
Figure 13. Sepsis Diagnostics: Fungal Sepsis Market Value, 2014-2016, $million
Figure 14. Sepsis Diagnostics: Bacterial Sepsis Market Value, 2014-2016, $million
Figure 15. Sepsis Diagnostics: Gram-positive Bacterial Sepsis Market Value, 2014-2016, $million
Figure 16. Sepsis Diagnostics: Gram-negative Bacterial Sepsis Market Value, 2014-2016, $million
Figure 17. Sepsis Diagnostics: Other Pathogen Market Value, 2014-2016, $million
Figure 18. Sepsis Diagnostics: U.S. Market Value, 2014-2016, $million
Figure 19. Sepsis Diagnostics: U.S. Market Value, 2017-2025, $million
Figure 20. Sepsis Diagnostics: Canada Market Value, 2014-2016, $million
Figure 21. Sepsis Diagnostics: Canada Market Value, 2017-2025, $million
Figure 22. Sepsis Diagnostics: Mexico Market Value, 2014-2016, $million
Figure 23. Sepsis Diagnostics: Mexico Market Value, 2017-2025, $million
Figure 24. Sepsis Diagnostics: UK Market Value, 2014-2016, $million
Figure 25. Sepsis Diagnostics: UK Market Value, 2017-2025, $million
Figure 26. Sepsis Diagnostics: Germany Market Value, 2014-2016, $million
Figure 27. Sepsis Diagnostics: Germany Market Value, 2017-2025, $million
Figure 28. Sepsis Diagnostics: France Market Value, 2014-2016, $million
Figure 29. Sepsis Diagnostics: France Market Value, 2017-2025, $million
Figure 30. Sepsis Diagnostics: Spain Market Value, 2014-2016, $million
Figure 31. Sepsis Diagnostics: Spain Market Value, 2017-2025, $million
Figure 32. Sepsis Diagnostics: Italy Market Value, 2014-2016, $million
Figure 33. Sepsis Diagnostics: Italy Market Value, 2017-2025, $million
Figure 34. Sepsis Diagnostics: Rest of Europe Market Value, 2014-2016, $million
Figure 35. Sepsis Diagnostics: Rest of Europe Market Value, 2017-2025, $million
Figure 36. Sepsis Diagnostics: China Market Value, 2014-2016, $million
Figure 37. Sepsis Diagnostics: China Market Value, 2017-2025, $million
Figure 38. Sepsis Diagnostics: Japan Market Value, 2014-2016, $million
Figure 39. Sepsis Diagnostics: Japan Market Value, 2017-2025, $million
Figure 40. Sepsis Diagnostics: India Market Value, 2014-2016, $million
Figure 41. Sepsis Diagnostics: India Market Value, 2017-2025, $million
Figure 42. Sepsis Diagnostics: Australia Market Value, 2014-2016, $million
Figure 43. Sepsis Diagnostics: Australia Market Value, 2017-2025, $million
Figure 44. Sepsis Diagnostics: South Korea Market Value, 2014-2016, $million
Figure 45. Sepsis Diagnostics: South Korea Market Value, 2017-2025, $million
Figure 46. Sepsis Diagnostics: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 47. Sepsis Diagnostics: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 48. Sepsis Diagnostics: Brazil Market Value, 2014-2016, $million
Figure 49. Sepsis Diagnostics: Brazil Market Value, 2017-2025, $million
Figure 50. Sepsis Diagnostics: Saudi Arabia Market Value, 2014-2016, $million
Figure 51. Sepsis Diagnostics: Saudi Arabia Market Value, 2017-2025, $million
Figure 52. Sepsis Diagnostics: South Africa Market Value, 2014-2016, $million
Figure 53. Sepsis Diagnostics: South Africa Market Value, 2017-2025, $million
Figure 54. Sepsis Diagnostics: Rest of LAMEA Market Value, 2014-2016, $million
Figure 55. Sepsis Diagnostics: Rest of LAMEA Market Value, 2017-2025, $million

COMPANIES MENTIONED

The top players in the global sepsis diagnostics market include T2 Biosystems, Inc., bioMérieux SA, Thermo Fisher Scientific Inc., Cepheid, Nanosphere, Inc., Abbott Laboratories, Becton, Dickinson and Company, Roche Diagnostics Limited, Bruker Corporation, and Beckman Coulter, Inc.